Personal history of other diseases of the circulatory system. Z86.79 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM Z86.79 became effective on October 1, 2018.
Personal history of other endocrine, nutritional and metabolic disease. Z86.39 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM Z86.39 became effective on October 1, 2018.
Z87.19 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z87.19 became effective on October 1, 2021. This is the American ICD-10-CM version of Z87.19 - other international versions of ICD-10 Z87.19 may differ. Z codes represent reasons for encounters.
Personal history of in-situ neoplasm of breast. Z86.000 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM Z86.000 became effective on October 1, 2018.
The 2022 edition of ICD-10-CM N60. 81 became effective on October 1, 2021. This is the American ICD-10-CM version of N60.
Benign endometrial hyperplasia N85. 01 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM N85. 01 became effective on October 1, 2021.
ICD-10 code Z92. 89 for Personal history of other medical treatment is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
History of falling81 - History of falling is a sample topic from the ICD-10-CM. To view other topics, please log in or purchase a subscription. ICD-10-CM 2022 Coding Guide™ from Unbound Medicine.
(HY-per-PLAY-zhuh) An increase in the number of cells in an organ or tissue. These cells appear normal under a microscope. They are not cancer, but may become cancer. Enlarge.
Atypical hyperplasia is a precancerous condition that affects cells in the breast. Atypical hyperplasia describes an accumulation of abnormal cells in the milk ducts and lobules of the breast. Atypical hyperplasia isn't cancer, but it increases the risk of breast cancer.
When a patient has a history of cerebrovascular disease without any sequelae or late effects, ICD-10 code Z86. 73 should be assigned.
Transfusion associated circulatory overload E87. 71 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E87. 71 became effective on October 1, 2021.
ICD-10 code D69. 6 for Thrombocytopenia, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
However, coders should not code Z91. 81 as a primary diagnosis unless there is no other alternative, as this code is from the “Factors Influencing Health Status and Contact with Health Services,” similar to the V-code section from ICD-9.
Atypical hyperplasia of the breast reflects proliferation of dysplastic epithelial cell populations. It is felt to be a transitional zone between benign and malignant breast disease, containing some but not all features of a cancer.
CLINICAL ACTIONS: Atypical hyperplasia of the breast is a benign but high-risk condition that can be either ductal (ADH) or lobular (ALH); these occur with equal frequency and together are found in about 10% of breast biopsies. Either entity confers a long-term risk of breast cancer that approaches 30% at 25 years of follow-up.